Surgical treatment of epileptic encephalopathy with spike-and-wave activation in sleep: A systematic review and meta-analysis

被引:1
|
作者
Ma, Yitao [1 ]
Kaminski, Matthew [2 ]
Kim, Alex [1 ]
机构
[1] Walter Reed Natl Mil Med Ctr, Dept Neurol, Bethesda, MD 20814 USA
[2] Univ Maryland, College Pk, MD USA
来源
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY | 2024年 / 119卷
关键词
Epileptic encephalopathy; Drug resistant epilepsy; Electroencephalogram; Surgery; Hemispherectomy; Outcome studies; ELECTRICAL STATUS EPILEPTICUS; MULTIPLE SUBPIAL TRANSECTION; LANDAU-KLEFFNER-SYNDROME; CORPUS CALLOSOTOMY; SLOW SLEEP; FOLLOW-UP; CHILDREN; ESES; POLYMICROGYRIA; HEMISPHEROTOMY;
D O I
10.1016/j.seizure.2024.05.008
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: Epileptic Encephalopathy / Developmental Epileptic Encephalopathy with spike-and-wave activation during sleep (EE/DEE-SWAS) is a self-limiting childhood epilepsy syndrome but may cause permanent neurocognitive impairment. Surgical interventions have been controversial in the treatment of EE/DEE-SWAS. This systematic review aims to evaluate the efficacy of various surgical procedures on the outcomes of EE/DEE-SWAS. Methods: A systematic review was performed per the PRISMA guidelines. A total of 14 retrospective studies were identified, comprising 131 cases of EE/DEE-SWAS treated with epilepsy surgery. The review analyzed presurgical data, surgical interventions, as well as outcomes related to seizures, EEG, and neuropsychological assessments. Results: Epilepsy surgery was successfully performed in 131 cases with minor complications. The average age was 2.6 years at seizure onset and 5.0 years at diagnosis of SWAS. Excellent seizure control (Engel I and II) was achieved in 80.6 %, 78.6 %, 77.4 % and 27.2 % of patients receiving hemispherectomies, focal resections, multiple subpial transections (MSTs), and corpus callosotomies (CCTs), respectively. EEG SWAS resolution was seen in 79.7 % of hemispherectomy cases, 78.6 % in focal resections, 63.9 % in MSTs, and 8.3 % in CCTs. Neurocognitive and behavioral improvement was noted in 58.0 %, 71.4 %, 58.3 % and 16.7 % for patients receiving hemispherectomies, focal resections, MSTs, and CCTs, respectively. A correlation between improved seizure control and SWAS resolution was observed with improved neuropsychological outcomes. Conclusion: Epilepsy surgery is a safe and effective treatment for carefully selected children with drug-resistant EE/DEE-SWAS. Patients who underwent epilepsy surgery had reduction of seizure burden, SWAS resolution and improvements in neurocognitive and behavioral function.
引用
收藏
页码:78 / 83
页数:6
相关论文
共 50 条
  • [1] Unmet needs in epileptic encephalopathy with spike-and-wave activation in sleep: A systematic review
    Chapman, Kevin E.
    Haubenberger, Dietrich
    Jen, Eric
    Tishchenko, Athena
    Nguyen, Trung
    Mcmicken, Carolyn
    EPILEPSY RESEARCH, 2024, 199
  • [2] The genetic landscape of developmental and epileptic encephalopathy with spike-and-wave activation in sleep
    Freibauer, Alexander E.
    RamachandranNair, Rajesh
    Jain, Puneet
    Jones, Kevin C.
    Whitney, Robyn
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2023, 110 : 119 - 125
  • [3] Serum Levels of Neuropeptides in Epileptic Encephalopathy With Spike-and-Wave Activation in Sleep
    Yasguclukal, Miray Atacan
    Ayca, Senem
    Demirbilek, Veysi
    Saltik, Sema
    Yalcinkaya, Cengiz
    Doventas, Yasemin Erdogan
    cokar, Ozlem
    PEDIATRIC NEUROLOGY, 2023, 144 : 110 - 114
  • [4] Evaluation of long-term neurocognitive functions in patients with epileptic encephalopathy with continuous spike-and-wave during sleep (CSWS)/epileptic encephalopathy with spike-and-wave activation in sleep (EE-SWAS)
    Sager, Gunes
    Takis, Gulnur
    Pinar, Zeynep Vatansever
    Duzkalir, Hanife
    Turkyilmaz, Ayberk
    Cag, Yakup
    Akin, Yasemin
    NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY, 2023, 53 (01):
  • [5] Exploratory analysis of high-dose corticosteroid therapy on epileptic encephalopathy with spike-and-wave activation in sleep
    Xiaoyue, Hu
    Hongwei, Tang
    Jianbiao, Wang
    Jingbo, Ma
    Ying, Hua
    FRONTIERS IN PEDIATRICS, 2024, 12
  • [6] Successful treatment of epileptic encephalopathy with spike wave activation in sleep with anakinra
    Ng, Andy Cheuk-Him
    Scantlebury, Morris H.
    EPILEPSY & BEHAVIOR REPORTS, 2024, 27
  • [7] Scalp EEG high frequency oscillations as a biomarker of treatment response in epileptic encephalopathy with continuous spike-and-wave during sleep (CSWS)
    Cao, Dezhi
    Chen, Yan
    Liao, Jianxiang
    Nariai, Hiroki
    Li, Lin
    Zhu, Yanwei
    Zhao, Xia
    Hu, Yan
    Wen, Feiqiu
    Zhai, Qiongxiang
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2019, 71 : 151 - 157
  • [8] Clinical analysis of developmental and/or epileptic encephalopathy with spike-and-wave activation in sleep: A single tertiary care center experience in China
    Zhang, Yunjian
    Li, Chunpei
    Zhou, Yuanfeng
    Yu, Lifei
    Zhang, Linmei
    Wang, Yi
    Zhou, Shuizhen
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2024, 119 : 52 - 57
  • [9] Developmental and/or epileptic encephalopathy with spike-and-wave activation in sleep in Saudi Arabia: Electroclinical, etiologic, genetic, and outcome multicenter study
    Alsini, Hanin
    Alghamdi, Abdulaziz
    Alshafi, Shatha
    Hundallah, Khalid
    Almehmadi, Sameer
    Alsowat, Daad
    Al-Yamani, Suad
    Almuzaini, Hanin
    Alwadie, Ali
    Al-Otaibi, Ali
    Jad, Lamyaa
    Almadhi, Asma
    Bashiri, Fahad
    Kentab, Amal
    Hamad, Muddathir H.
    Baarmah, Duaa
    Alrifaie, Mohammed
    Almuqbel, Mohammed
    Al Baradie, Raidah
    Mir, Ali
    Jan, Mohammed
    Muthaffar, Osama
    Aljabri, Mohammed
    Ali, Elsayed
    Saeed, Mohammed
    Matar, Abeer
    Tabarki, Brahim
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2023, 107 : 146 - 154
  • [10] Modulation index predicts the effect of ethosuximide on developmental and epileptic encephalopathy with spike-and-wave activation in sleep
    Shibata, Takashi
    Tsuchiya, Hiroki
    Akiyama, Mari
    Akiyama, Tomoyuki
    Kobayashi, Katsuhiro
    EPILEPSY RESEARCH, 2024, 202